%0 Journal Article
%A King, Sontoria D
%A Veliginti, Swathi
%A Brouwers, Martijn C G J
%A Ren, Zhewen
%A Zheng, Wei
%A Setiawan, Veronica Wendy
%A Wilkens, Lynne R
%A Shu, Xiao-Ou
%A Arslan, Alan A
%A Beane Freeman, Laura E
%A Bracci, Paige M
%A Canzian, Federico
%A Du, Mengmeng
%A Gallinger, Steven J
%A Giles, Graham G
%A Goodman, Phyllis J
%A Haiman, Christopher A
%A Kogevinas, Manolis
%A Kooperberg, Charles
%A Le Marchand, Loic
%A Neale, Rachel E
%A Visvanathan, Kala
%A White, Emily
%A Albanes, Demetrius
%A Andreotti, Gabriella
%A Babic, Ana
%A Berndt, Sonja I
%A Brais, Lauren K
%A Brennan, Paul
%A Buring, Julie E
%A Rabe, Kari G
%A Bamlet, William R
%A Chanock, Stephen J
%A Fuchs, Charles S
%A Gaziano, J Michael
%A Giovannucci, Edward L
%A Hackert, Thilo
%A Hassan, Manal M
%A Katzke, Verena
%A Kurtz, Robert C
%A Lee, I-Min
%A Malats, Nuria
%A Murphy, Neil
%A Oberg, Ann L
%A Orlow, Irene
%A Porta, Miquel
%A Real, Francisco X
%A Rothman, Nathaniel
%A Sesso, Howard D
%A Silverman, Debra T
%A Thompson, Ian M
%A Wactawski-Wende, Jean
%A Wang, Xiaoliang
%A Wentzensen, Nicolas
%A Yu, Herbert
%A Zeleniuch-Jacquotte, Anne
%A Yu, Kai
%A Wolpin, Brian M
%A Duell, Eric J
%A Li, Donghui
%A Hung, Rayjean J
%A Perdomo, Sandra
%A McCullough, Marjorie L
%A Freedman, Neal D
%A Patel, Alpa V
%A Peters, Ulrike
%A Riboli, Elio
%A Sund, Malin
%A Tjønneland, Anne
%A Zhong, Jun
%A Van Den Eeden, Stephen K
%A Kraft, Peter
%A Risch, Harvey A
%A Amundadottir, Laufey T
%A Klein, Alison P
%A Stolzenberg-Solomon, Rachael Z
%A Antwi, Samuel O
%T Genetic susceptibility to nonalcoholic fatty liver disease and risk for pancreatic cancer: Mendelian randomization.
%J Cancer epidemiology, biomarkers & prevention
%V 32
%N 9
%@ 1055-9965
%C Philadelphia, Pa.
%I AACR
%M DKFZ-2023-01267
%P 1265-1269
%D 2023
%Z 2023 Sep 1;32(9):1265-1269
%X There are conflicting data on whether nonalcoholic fatty liver disease (NAFLD) is associated with susceptibility to pancreatic cancer (PC). Using Mendelian randomization (MR), we investigated the relationship between genetic predisposition to NAFLD and risk for PC.Data from genome-wide association studies within the Pancreatic Cancer Cohort Consortium (PanScan; cases n=5090, controls n=8733) and the Pancreatic Cancer Case Control Consortium (PanC4; cases n=4,163, controls n=3,792) were analyzed. We used data on 68 genetic variants with four different MR methods (inverse variance weighting [IVW], MR-Egger, simple median, and penalized weighted median) separately to predict genetic heritability of NAFLD. We then assessed the relationship between each of the four MR methods and PC risk, using logistic regression to calculate odds ratios (ORs) and 95
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:37351909
%R 10.1158/1055-9965.EPI-23-0453
%U https://inrepo02.dkfz.de/record/277102